NCT07410494
- Conditions
- Acute Myeloid Leukemia (AML), Adenocarcinoma, Adnexal Diseases, +92 more
- Locations
-
- District One Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
Explore clinical trials studying Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma. Study availability and eligibility vary by location and protocol.
7 public trials
4 recruiting studies
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma trial results
NCT07309497
- Conditions
- Bispecific Antibody, Blood Protein Disorders, CART Therapy, +18 more
- Locations
-
- Inselspital Bern Bern, Switzerland
- Universitätsspital Zürich Zurich, Switzerland
NCT07305337
- Conditions
- Adherence Interventions, Behavior, Blood Protein Disorders, +25 more
- Locations
-
- Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
NCT07270263
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Embolism, +29 more
- Locations
-
- Department of Haematology & Transplantology Gdansk, Pomeranian Voivodeship, Poland
Not Yet Recruiting
Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study
NCT07634263
- Conditions
- Behavior, Blood Protein Disorders, Cardiovascular Diseases, +23 more
- Locations
-
- Copenhagen University Hospital (Rigshospitalet) Copenhagen, Denmark
- Odense University Hospital Odense, Denmark
- Sjællands Universitets Hospital Roskilde, Denmark
Not Yet Recruiting
Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study
NCT07558057
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- Aarhus University Hospital Aarhus, Denmark
NCT02992483
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- MD Anderson Cancer Center/University of Texas MD Anderson CC Houston, Texas, United States
- Novartis Investigative Site Heidelberg, Victoria, Australia
- Novartis Investigative Site Nantes, France
- Novartis Investigative Site Heidelberg, Germany